Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease

Neuroscience Letters

Volumn 298, Issue 1, 2001, Pages 78-80

  Aoyama, Koji ^a   Matsubara, Kazuo ^b   Kondo, Masahiro ^a   Murakawa, Yohko ^a   Suno, Manabu ^b   Yamashita, Kazuya ^a   Yamaguchi, Shuhei ^a   Kobayashi, Shotai ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Aging; Azaheterocyclic amines; Cerebrospinal fluid; N Methylation; Neurotoxicity; Parkinson's disease

Indexed keywords

NICOTINAMIDE METHYLTRANSFERASE;

ADULT; AGED; AGING; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; METHYLATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

AGING; FEMALE; HUMANS; MALE; METHYLTRANSFERASES; MIDDLE AGED; PARKINSON DISEASE;

EID: 0035951681     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01723-7     Document Type: Article

References (10)

1. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization
2. Substrate specificity of nicotinamide methyltransferase isolated from porcine liver
3. N-Methylation ability for azaheterocyclic amines is higher in Parkinson's disease: Nicotinamide loading test
4. Criteria for diagnosing Parkinson's disease
5. N-methylation of pyridines in Parkinson's disease
6. Bioactivation of azaheterocyclic amines via S-adenosyl-L-methionine-dependent N-methyltransferase
7. Human liver nicotinamide N-methyltransferase: Ion-pairing radiochemical assay, biochemical properties and individual variation
8. Fluorometric assay of rat brain N-methyltransferase with 4-methylnicotinamide
9. Nicotinamide methylation. Tissue distribution, developmental and neoplastic changes
10. Human nicotinamide N-methyltransferase pharmacogenetics: Gene sequence analysis and promoter characterization